2m 2m 2m 2m 2m 2m 2m
Azenta (AZTA)
NASDAQ
$23.90+$0.47 (+2.01%)
Price as of Jun 03, 2026 4:44 PM EDT- $1.1BMarket Cap
- -17.38%1-Year Change
- Medical Instruments & SuppliesIndustry
Azenta (AZTA)
$23.90+$0.47 (+2.01%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 173.2M -73.61% | 656.3M -1.32% | 665.1M +19.73% | 555.5M +8.14% | |
Cost of Revenue | 94.9M -75.85% | 393.0M -2.23% | 401.9M +34.02% | 299.9M +11.12% | |
Gross Profit | 270.3M +2.62% | 263.4M +0.09% | 263.1M +2.96% | 255.6M +4.83% | |
Sales and Marketing Expense | 261.6M -13.60% | 302.7M -4.28% | 316.3M +25.48% | 252.1M -0.01% | |
Research and Development Expense | -30.4M -9.35% | -33.5M -1.27% | -34.0M +23.29% | -27.5M +22.89% | |
Depreciation and Amortization Expense | 61.2M -32.55% | 90.7M +6.03% | 85.6M +59.37% | 53.7M -17.80% | |
Total Operating Expenses | 297.1M -35.97% | 464.0M +38.00% | 336.3M +19.96% | 280.3M +1.97% | |
Operating Profit | -26.8M -86.62% | -200.7M +174.43% | -73.1M +195.64% | -24.7M -20.44% | |
Interest Income | 3.4M -89.75% | 33.2M -24.14% | 43.7M +115.59% | 20.3M +3,109.81% | |
Interest Expense | N/A N/A | N/A N/A | -4.6M 0.00% | -4.6M +125.28% | |
Interest Income and Expense and Net | 3.4M -89.75% | 33.2M -15.25% | 39.1M +149.39% | 15.7M +1,217.22% | |
Total Nonoperating Income and Expense | 922,000 +417.98% | 178,000 +117.08% | -1.0M +291.73% | -266,000 -98.39% | |
Income before Taxes | -7.1M -95.73% | -167.3M +449.81% | -30.4M +206.29% | -9.9M -79.71% | |
Income Taxes | -31.6M +902.25% | -3.2M -82.03% | -17.6M -1,400.00% | 1.4M +106.72% | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -55.8M -66.03% | -164.2M +1,051.50% | -14.3M -100.67% | 2.1B +1,825.88% | |
Net Income from Continuing Operations Applicable to Common | 24.5M +114.90% | -164.2M +439.45% | -30.4M +206.29% | -9.9M -79.71% | |
Basic EPS and Net Income | -1.22 -60.52% | -3.09 +1,304.55% | -0.22 -100.77% | 28.48 +1,811.41% | |
Diluted EPS and Net Income | -1.22 -60.52% | -3.09 +1,304.55% | -0.22 -100.77% | 28.48 +1,811.41% | |
Basic Weighted Average Shares | 45.7M -13.98% | 53.2M -19.74% | 66.3M -11.54% | 74.9M +0.90% | |
Diluted Weighted Average Shares | 45.9M -13.69% | 53.2M -19.74% | 66.3M -11.54% | 74.9M +0.59% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 279.8M -10.02% | 310.9M -54.20% | 678.9M +3.13% | 658.3M +189.44% | |
Short-Term Investments | 61.1M -59.56% | 151.2M -55.39% | 338.9M -62.83% | 911.8M +1,125,534.57% | |
Cash and Cash Equivalents and Short-Term Investments | 340.9M -26.22% | 462.1M -54.60% | 1.0B -35.17% | 1.6B +590.10% | |
Total Current Assets | 708.3M -14.95% | 832.8M -41.31% | 1.4B -42.30% | 2.5B +216.37% | |
Accumulated Depreciation | 166.0M +7.63% | 154.2M +34.27% | 114.9M +36.68% | 84.0M -36.31% | |
Property and Plant and Equipment and Net | 154.0M -24.03% | 202.7M -1.50% | 205.7M +33.19% | 154.5M +18.17% | |
Total Long-Term Assets | 6.1M -43.68% | 10.9M -84.59% | 70.5M +23.43% | 57.1M -1.68% | |
Total Assets | 2.1B -1.93% | 2.1B -27.23% | 2.9B -22.35% | 3.7B +104.24% | |
Income Taxes Payable | 27.7M -59.30% | 68.0M -28.95% | 95.7M +1.05% | 94.7M +299.17% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 237.7M +16.03% | 204.8M -2.89% | 210.9M -8.51% | 230.5M -33.19% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 49.7M +0.05% | 49.7M 0.00% | |
Total Long-Term Liabilities | 11.1M -13.41% | 12.9M +5.69% | 12.2M +88.38% | 6.5M +4.70% | |
Total Liabilities | 332.6M +0.46% | 331.1M -5.74% | 351.2M -0.43% | 352.7M -28.62% | |
Retained Earnings | 1.4B -3.85% | 1.5B -10.00% | 1.6B -0.87% | 1.7B +452.17% | |
Total Stockholders Equity | 1.7B -2.37% | 1.8B -30.20% | 2.5B -24.64% | 3.4B +153.78% | |
Total Shares Outstanding | 45.9M +0.63% | 45.6M -21.20% | 57.8M -22.91% | 75.0M +0.91% | |
Cash Flow | |||||
Cash from Operating Activities | 72.2M +43.53% | 50.3M +187.53% | 17.5M +103.75% | -466.0M -410.99% | |
Capital Expenditures | 33.9M -9.45% | 37.4M -5.18% | 39.4M -46.30% | 73.4M +39.07% | |
Cash from Investing Activities | -90.5M -140.25% | 224.7M -47.90% | 431.4M -70.57% | 1.5B +1,101.43% | |
Dividends Paid | N/A N/A | 0 -100.00% | 7.5M 0.00% | 7.5M -74.79% | |
Cash from Financing Activities | -9.6M -98.55% | -659.2M -21.90% | -844.1M +1,244.89% | -62.8M +142.27% | |
Financials Ratio | |||||
Gross Margin | 45.21% +12.66% | 40.13% +1.42% | 39.57% -14.01% | 46.01% -3.06% | |
Operating Margin | -15.50% -49.31% | -30.58% +178.09% | -11.00% +146.93% | -4.45% -26.42% | |
Return on Assets | -2.68% -59.29% | -6.59% +1,424.80% | -0.43% -100.56% | 77.06% +1,075.45% | |
Return on Equity | -3.19% -58.19% | -7.63% +1,478.01% | -0.48% -100.53% | 90.98% +942.87% | |
Revenue Growth | -73.61% +5,495.76% | -1.32% -106.67% | 19.73% +142.45% | 8.14% +119.03% | |
Current Ratio | 2.98 -26.70% | 4.07 -39.56% | 6.73 -36.94% | 10.67 +373.54% | |
Cash Ratio | 1.18 -22.45% | 1.52 -52.84% | 3.22 +12.73% | 2.86 +333.28% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow